The Myelin Repair Foundation Blog
We are Biotech, Are You?
“I Am Biotech” is donating $25 to a charity for every story they receive from a person working in biotech. One of the charities on their list of recipients is the Myelin Repair Foundation (MRF). If you work in the biotech field (in any type of position) and you want to help speed up...
“There is Desperate Need for New Drug Targets”
The Silicon Valley/San Jose Business Journal recently covered the Myelin Repair Foundation, giving an outline of our ARC research model and our goals. Scott Johnson, Founder and President of the MRF & MS patient Quote: Johnson and his initial advisory team set out to narrowly define what is the...
The MRF’s Research Demonstrates That Remyelination Possible
In 2004, the MRF promised to identify, validate and license the first of many myelin repair drug targets by 2009, and to bring an effective myelin repair treatment for MS to market by 2019. In our latest summary of scientific findings (PDF), the MRF shares the cumulative progress made by its scientific...
Investing in patient-focused research
From the beginning, it has been part and parcel of the MRF’s Accelerated Research Collaboration model to make patient treatments the singular focus of all of our work. While this may sound obvious, it is not supported by the culture and mindset of most basic scientists working in university laboratories....
Stop and Pink
Ah, it’s October again. The time of year when the days get shorter, the nights get colder, and on Sundays, you notice that the San Francisco 49ers are wearing pink shoes. Yes, October is Breast Cancer Awareness month, which means pink ribbons. Are. Everywhere. The pink ribbon is a marketing...
Blast from the Past: September 29, 2004
Back in September 2004, when we just started funding collaborative research with our different laboratories, a Wall Street Journal article, “Anxious for Cures, Grant Givers Turn More Demanding” came out highlighting one of the very first benefits from our collaborative model. In this article,...
Thank You Wilson Sonsini Goodrich Rosati!
One of the key reasons for the success of the Myelin Repair Foundation’s research efforts is the support we have received from our legal team at Wilson Sonsini Goodrich & Rosati (WSGR). Over the past six years, WSGR has provided the MRF with more than $800,000 in pro-bono legal services. Their...
Recent Comments